Common questions about Avastin (Antineoplastic) (FAQ)
Q: What are the most common side effects people report from Avastin?
According to official product information, the most frequently observed adverse reactions are those that affect more than 1 in 10 patients. These commonly reported effects include high blood pressure (hypertension), fatigue, general weakness (asthenia), diarrhea, nausea, and having too much protein in the urine (proteinuria).
Q: Can Avastin cause problems with high blood pressure?
Yes. Regulatory documents state that Avastin can cause new or worsening high blood pressure (hypertension) as a very common side effect. In some instances, it may lead to a severe high blood pressure event known as a hypertensive crisis, which is classified as a serious adverse reaction.
Q: Why is there a risk of bleeding or blood clots with Avastin?
Avastin works by inhibiting a protein called Vascular Endothelial Growth Factor (VEGF). The inhibition of VEGF by Avastin is associated with an increased risk of severe bleeding (hemorrhage) and the formation of blood clots (thromboembolic events), according to regulatory information.
Q: How does Avastin impact wound healing?
Official labeling states that Avastin can impair the wound healing process and may cause complications, such as the separation of a wound (dehiscence). Treatment initiation is restricted for a minimum of 28 days before and following major surgery. Regulatory documents restrict treatment initiation until any surgical incision is completely healed.
Q: Is Avastin treatment always given with other drugs?
For most of the FDA-approved cancer indications, Avastin is used in combination with specific chemotherapy regimens or other therapeutic agents. However, for certain indications, such as progressive glioblastoma or some ovarian cancers, it may be used as a single agent (monotherapy).
Q: How long is a typical course of Avastin treatment?
The length of treatment varies by the type of cancer and the treatment plan. For most indications, the treatment is typically continued until there is documented evidence of disease progression or until the patient experiences unacceptable side effects. Specific regimens may have a set maximum number of cycles.
Q: Is it normal to feel very fatigued after an Avastin infusion?
Yes. Fatigue and asthenia, which is a feeling of abnormal weakness, are both listed in the official safety information as very common adverse reactions associated with Avastin treatment.
Q: Are certain side effects more common in older adults?
Official safety information notes that patients aged 65 years and older have a documented increased risk of developing specific adverse reactions. These include arterial blood clots (thromboembolic events) and hypertension (high blood pressure), compared to younger patients.
Q: Is Avastin only given intravenously (IV)?
Yes. The medicine must be administered exclusively as an intravenous (IV) infusion, meaning it is injected into a vein. It is not intended for IV push or bolus administration, as required by official instructions.
Q: Is Avastin an option for people with pre-existing heart conditions?
Official documents advise that caution is required for patients who have pre-existing cardiovascular disease. This is due to a documented increased risk of congestive heart failure associated with Avastin treatment in certain populations.
Q: Does Avastin work for colon cancer that has spread?
Yes, Avastin is approved for the treatment of patients with metastatic colorectal cancer (mCRC), which refers to colon cancer that has spread to distant parts of the body.
Q: Why do doctors sometimes use Avastin for brain tumors?
Avastin has an approved indication for the treatment of patients with recurrent glioblastoma (rGBM). This is a specific type of aggressive brain tumor that has progressed or returned after prior treatment.
Q: How long does the effect of Avastin usually last after an infusion?
The terminal half-life of bevacizumab, the active ingredient in Avastin, is typically estimated to be around 20 days. This pharmacokinetic measure indicates the time it takes for the concentration of the drug in the body to be reduced by half.
Q: Is hair loss a common side effect of Avastin?
Hair loss (alopecia) is not listed among the most common adverse reactions when looking at the safety profile of Avastin alone. However, since the drug is often given in combination with chemotherapy, hair loss may occur due to the co-administered chemotherapy drugs.
Q: What should I watch out for regarding vision changes while on Avastin?
Vision problems can be a sign of certain rare but serious conditions. These include Posterior Reversible Encephalopathy Syndrome (PRES) or hemorrhage (bleeding) in the eye. Monitoring for vision changes typically occurs during treatment.
Q: Are headaches a normal side effect of Avastin treatment?
Yes. Headache is listed in official safety information as one of the most common adverse reactions reported in patients receiving Avastin.
Q: Why might a patient have to stop taking Avastin?
Official dose modification guidelines state that Avastin is to be permanently discontinued if a patient develops severe events. These include a hole in the stomach or intestine (gastrointestinal perforation), a severe arterial blood clot, a hypertensive crisis, or nephrotic syndrome (a severe kidney disorder).
Q: What is Anti-Angiogenesis?
Anti-angiogenesis is the medical term for inhibiting the growth of new blood vessels. Avastin is classified as an anti-angiogenic agent because it specifically targets the Vascular Endothelial Growth Factor (VEGF) protein, which is the signal that tumors use to grow a new blood supply.
Q: Are there studies showing Avastin's effectiveness in earlier cancer stages?
Yes, studies have shown effectiveness for some cancers in earlier stages. For instance, Avastin is approved for use in combination with chemotherapy for certain Stage III or IV ovarian, fallopian tube, or primary peritoneal cancers following initial surgical treatment.
Q: What is the latest research on using Avastin for recurrent cancers?
Avastin is approved for treating several types of recurrent cancers, including recurrent glioblastoma, persistent or recurrent cervical cancer, and platinum-sensitive or platinum-resistant recurrent ovarian cancer. These approvals were based on clinical studies demonstrating benefit in these advanced settings.
Q: What are the signs of an allergic reaction to Avastin?
Infusion-related reactions may occur, which can include signs of a serious allergic reaction (hypersensitivity). These signs can include difficulty breathing, decreased oxygen in the blood, severe high blood pressure, chest pain, and excessive sweating. Patients are typically monitored for these signs during the infusion.
Q: Are there specific criteria for stopping Avastin due to side effects?
Yes. Official guidelines specify certain severe side effects, like a hypertensive crisis or a gastrointestinal perforation, that require the drug to be permanently stopped. Less severe side effects may require a temporary suspension of treatment until the reaction improves.
Q: Is Avastin a curative treatment or is it mainly palliative?
Avastin is generally indicated for the treatment of advanced, metastatic, or recurrent cancers. Clinical study endpoints for approval, such as overall survival and progression-free survival, are typically measures evaluated in the context of life-extending or supportive care for advanced disease.
Q: What kind of research led to the approval of Avastin?
The approvals for Avastin were based on the results of randomized, controlled Phase III clinical trials. These studies demonstrated a statistically significant improvement in outcomes, such as overall survival or progression-free survival, when Avastin was added to standard chemotherapy regimens.
Q: Do patients need special monitoring during Avastin treatment?
Yes. Patients require careful monitoring for high blood pressure and need regular tests for excess protein in the urine (proteinuria). Furthermore, patients are closely monitored for any signs of infusion-related reactions during and immediately following the administration.
Q: Are there certain foods to avoid when on Avastin?
The official product preparation instructions specify that Avastin must not be mixed or diluted with solutions that contain dextrose (a type of sugar). There are no specific food restrictions listed in the official label.
